Group One Trading
ONCT

Group One Trading’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Group One Trading’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,040
Closed -$22.3K – 8474
2022
Q2 		$23K Buy
1,040
+871
+515% +$19.4K ﹤0.01% 6204
2022
Q1 		$5K Sell
169
-286
-63% -$10.4K ﹤0.01% 7492
2021
Q4 		$21K Buy
+455
New +$30.6K ﹤0.01% 6965
2021
Q3 		– Sell
-1,770
Closed -$146K – 8957
2021
Q2 		$168K Buy
1,770
+485
+38% +$57.6K ﹤0.01% 5424
2021
Q1 		$214K Buy
1,285
+1,275
+12,750% +$169K ﹤0.01% 4963
2020
Q4 		$1K Hold
10
– – ﹤0.01% 6372
2020
Q3 		$0 Hold
10
– – ﹤0.01% 6670
2020
Q2 		$1K Hold
10
– – ﹤0.01% 5692
2020
Q1 		$1K Hold
10
– – ﹤0.01% 5133
2019
Q4 		$1K Hold
10
– – ﹤0.01% 5016
2019
Q3 		$1K Buy
+10
New +$1.02K ﹤0.01% 5031
2016
Q4 		– Hold
0
– – – 4935
2016
Q3 		– Hold
0
– – – 5005
2016
Q2 		– Sell
-30
Closed -$28K – 5026
2016
Q1 		$21K Buy
30
+5
+20% +$4.33K ﹤0.01% 3725
2015
Q4 		$24K Sell
25
-6
-19% -$7.93K ﹤0.01% 3829
2015
Q3 		$33K Sell
31
-10
-24% -$14.6K ﹤0.01% 3785
2015
Q2 		$85K Buy
41
+23
+128% +$32.7K ﹤0.01% 3192
2015
Q1 		$17K Sell
18
-2
-10% -$1.99K ﹤0.01% 3964
2014
Q4 		$20K Buy
20
+1
+5% +$893 ﹤0.01% 3947
2014
Q3 		$19K Buy
19
+2
+12% +$2.95K ﹤0.01% 4144
2014
Q2 		$32K Buy
17
+1
+6% +$1.98K ﹤0.01% 3851
2014
Q1 		$34K Buy
+16
New +$39.9K ﹤0.01% 3913

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Group One Trading's ONCT Position: Q3 2022 in Review

Group One Trading sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2022, closing a stake of 1,040 shares — an estimated $22.3K sold.

Group One Trading first reported a position in ONCT in Q1 2014 and held it in 20 quarters. The position peaked at $214K in Q1 2021. 61 funds tracked by Wall St. Rank hold ONCT as of Q3 2022.

  • Group One Trading reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 1,040 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $22.3K.
  • Group One Trading first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2014 and held it in 20 quarters.
  • Group One Trading's Oncternal Therapeutics, Inc. Common Stock position peaked at $214K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.